A new species of the mygalomorph spider genus Euagrus Ausserer (Araneae: Euagridae) from central Mexico and new records of E. gus Coyle from Tlaxcala

Posted by
  A new species of the mygalomorph spider genus Euagrus Ausserer (Araneae: Euagridae) from central Mexico and new records of E. gus Coyle from Tlaxcala Abstract  A new species of the spider genus Euagrus Ausserer, 1875 from temperate pine-oak forests in the states of Tlaxcala and Hidalgo, Mexico is described: E. pulque sp. nov. The description of the new species is based on male and female adult specimens. Additionally, Euagrus gus Coyle, 1988 is recorded for the very first time in the state of Tlaxcala. These species have sympatric distributions in La Malinche National Park, Tlaxcala. With this description, the diversity of the genus increases to 23 species, with Mexico harboring the highest diversity with 17 described species.  Valdez-Mondragón, A., Salinas-Velasco, H. V. & Bueno-Villegas, J. (2026). A new species of the mygalomorph spider genus Euagrus Ausserer (Araneae: Euagridae) from central Mexico and new records of E. gus Coyle from Tlaxcala. Zootaxa 5810 (...

Patentability of natural products from Venomous Organisms: A guide for life science researchers

Posted by

 


Patentability of natural products from Venomous Organisms: A guide for life science researchers

Abstract

This report is built on insights gathered during the European Venom Network (EUVEN) workshop on the patentability of natural compounds, with a particular focus on venom-derived molecules, held online on June 10, 2022. The program explored key aspects of Intellectual Property (IP) rights relevant to the development of therapeutic agents derived from natural sources, including animal venoms and toxins. Topics included IP considerations in biotechnology, strategies for building and managing IP portfolios, and licensing pathways from academic research to industry. The review further discusses the specific challenges and opportunities in patenting venom-based compounds, and outlines recommended practices for IP sharing within collaborative research consortia such as EUVEN. Finally, it incorporates perspectives from industry on fostering academic partnerships to advance the translational potential of venom-derived therapeutics. This document aims to serve as a practical guide for researchers at all career stages working in life sciences, particularly those engaged in the discovery and development of natural product-based innovations.
Ikonomopoulou, M. P., Anderluh, G., Coskun, S., Merello Luna, F., Modica, M. V., Procházka, J., Rivera-de-Torre, E., Tarallo, A., & Violette, A. (2025). Patentability of natural products from Venomous Organisms: A guide for life science researchers. Toxicon, 108927. https://doi.org/10.1016/j.toxicon.2025.108927